Jeil Pharmaceutical Headquarters in Seocho-gu, Seoul (Photo by Jeil Pharmaceutical)

Jeil Pharmaceutical Headquarters in Seocho-gu, Seoul (Photo by Jeil Pharmaceutical)

View original image

[Asia Economy Reporter Chunhee Lee] Jeil Pharmaceutical announced on the 28th that it will participate in the world's largest pharmaceutical and bio conference, 'CPhI Worldwide 2022 (Convention on Pharmaceutical Ingredients Worldwide 2022)'.


CPhI, the world's largest pharmaceutical exhibition, is a global conference that, as of 2019 before the COVID-19 pandemic, attracted more than 2,500 companies and over 48,000 pharmaceutical professionals from more than 170 countries worldwide. This year's CPhI Worldwide 2022 will be held both online and offline from July 1 to 3 (local time) in Frankfurt, Germany.


At this exhibition, Jeil Pharmaceutical plans to participate by selecting four major product lines: active pharmaceutical ingredients, finished pharmaceuticals, patch products, and cosmetics. Through this event, Jeil Pharmaceutical aims to enhance its recognition in the global market by showcasing products manufactured under strict GMP management with competitive quality, while intensively promoting to potential clients.


In particular, it is expected that business cooperation discussions with global pharmaceutical companies will take place regarding its new drug pipeline, including its self-developed fixed-dose combination improved drugs and the reflux esophagitis treatment 'JP-1366', a P-CAB (potassium-competitive acid blocker)-based drug currently in Phase 3 clinical trials through its subsidiary Onconic Therapeutics.



A Jeil Pharmaceutical official stated, "Participation in this conference will be a meaningful opportunity to accelerate global business that was delayed due to the COVID-19 pandemic," adding, "We also plan to seek partnerships with global companies for various new businesses such as technology transfer and introduction, as well as local production of finished products."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing